Cite
HARVARD Citation
Kudo, M. et al. (2020). Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 69 (8), pp. 1492-1501. [Online].